U-RHYTHM TEAM
We are team of dynamics experts, design engineers and entrepreneurs. Our ultimate goal is to share the device with the larger medical and research communities.
Stafford Lightman
Inventor, Clinical Endocrinologist, Neuroscientist, and Co Founder of Dynamic Therapeutics
A Professor of Medicine at the University of Bristol, Royal Society Fellow, Immediate Past President of the British Neuroscience Association, and an International leader in the field of neuroendocrinology. Stafford is keen to share this technology so others can benefit from insights into biological rhythms.
Georgina Hazell
Neuroendocrinologist and Co Founder of Dynamic Therapeutics
A neuroendocrinologist with a background in dynamic research. Her work has further highlighted the importance of biological rhythms in health and disease. Georgina has completed a Royal Society of Edinburgh/BBSRC Enterprise Fellowship and iCURE innovation to commercialisation course to help commercialise the U-RHYTHM device.
Alex Caccia
Deep tech Entrepreneur and Co Founder of Dynamic Therapeutics
Alex Caccia is an entrepreneur with start-up experience in deep technology, manufacturing and a background in finance and investment banking. Alex has a successful track record of raising finance for early-stage technology businesses.
Thomas Upton
Clinical Research Fellow in Automated Sampling
A clinical fellow using the U-RHYTHM device to improve diagnostics and treatment of patients with endocrine disorders, and investigate rhythms in everyday life. Thomas, along with colleagues at the University of Bristol, and collaborators in the UK and Europe, have been pivotal in the development of the U-RHYTHM system.
Designworks
Creative product design consultancy
Designworks LTD is an award-winning rapid design and manufacturing business with 25 years of experience working in the medical technology sector. Their exceptional team of talented designers and engineers have transformed the U-RHYTHM device from early proof-of concept to a third-generation prototype. The devices have now been used on hundreds of participants across Europe.